Investor Presentaiton slide image

Investor Presentaiton

Delivering on Commitments in 2017 10 $M Revenue What We Said What We Did Status 930-950 972 Adjusted EBITDA(1) 215-225 243 Capex 60-65 53 Free Cash Flow(1) 80-90 122 Net Debt to Adjusted EBITDA(1) Performance Materials Performance Chemicals 1.5 to 1.75x Revenue to double in 5-7 years; margins above 40% Margins to 18%-20% in 24-36 months 1.2x 16% revenue growth, 40.6% EBITDA(1) margin 16.2% EBITDAmargin; up from 13.0% in 2016 (1) Please see appendices included at the end of this presentation for Ingevity's use of non-GAAP financial measures, definitions of those financial measures as well as the reconciliation to the nearest GAAP financial measure. Ingevity
View entire presentation